Featured Industry

Pharmaceuticals: Just one of the many industries we serve.

Pharmaceuticals

With our SEAS technology, we can simulate the various risk-return payoffs, future scenarios on likely introduction of a drug or expiration of a patent. Implementation for any marketing plan, merger, take-over, price cuts or R&D investment can be achieved in virtual space.

Intelligent agents can represent small, medium, and larger pharmaceutical firms. Each simulation can be customized as per client specifications.


About Us

Where We’ve Been

Synthetic Environments for Analysis and Simulation (SEAS) is the brainchild of Dr. Alok R. Chaturvedi. He got this idea during the briefing of Synthetic Theater of War (STOW) at the Institute for Defense Analyses (IDA), in January 1993. In collaboration with Dr. Shailendra Raj Mehta, Dr. Chaturvedi directed the research project at Purdue University’s Krannert School of Management. This project would soon develop into the first version of SEAS.

After SEAS matured and was patented, the U.S. Department of Defense took interest in the project and requested a configured version to fit their needs. In March 1999, after securing an exclusive license to market the SEAS technology from Purdue, Dr. Chaturvedi (Chief Technology Officer) and Dr. Mehta (Chief Economist) founded SEAS LLC along with Cheemun Foong, our employee number one, as they embarked on an exciting journey. SEAS LLC and subsequently, Simulex, Inc. was born.

Where We’re Going

In just 14 years, Simulex, Inc. has established itself as a visionary in the technology industry. We have doubled in size, now employing a team of over thirty experienced, multi-disciplined programmers and project managers. Our portfolio continues to grow with the support of the U.S. Department of Defense and several Fortune 500 companies.